The present study was specifically designed to explore the relationships between circulating levels of PCSK9, comprehensive circulating determinants of the atherosclerotic risk and precise characterization of coronary artery disease in contemporary patient populations with suspected CAD. This evidence concerns the gene PCSK9 and coronary artery disorder.